Shuai Jiang, Christina Robinson, Joseph Anderson, William Hisey, Lynn Butterly, Arief Suriawinata, Saeed Hassanpour
{"title":"Improving Colorectal Cancer Screening and Risk Assessment through Predictive Modeling on Medical Images and Records.","authors":"Shuai Jiang, Christina Robinson, Joseph Anderson, William Hisey, Lynn Butterly, Arief Suriawinata, Saeed Hassanpour","doi":"10.1016/j.ajpath.2025.09.016","DOIUrl":null,"url":null,"abstract":"<p><p>Colonoscopy screening effectively identifies and removes polyps before they progress to colorectal cancer (CRC), but current follow-up guidelines rely primarily on histopathological features, overlooking other important CRC risk factors. Variability in polyp characterization among pathologists also hinders consistent surveillance decisions. Advances in digital pathology and deep learning enable the integration of pathology slides and medical records for more accurate progression risk prediction. Using data from the New Hampshire Colonoscopy Registry, including longitudinal follow-up, a transformer-based model for histopathology image analysis was adapted to predict 5-year progression risk. Multi-modal fusion strategies were further explored to combine clinical records with deep learning-derived image features. Training the model to predict intermediate clinical variables improved 5-year progression risk prediction (AUC = 0.630) compared to direct prediction (AUC = 0.615, p = 0.013). Integrating WSI-based model predictions with non-imaging features further improved performance (AUC = 0.672), significantly outperforming the non-imaging-only approach (AUC = 0.666, p = 0.002). These results highlight the value of integrating diverse data modalities with computational methods to enhance progression risk stratification.</p>","PeriodicalId":7623,"journal":{"name":"American Journal of Pathology","volume":" ","pages":""},"PeriodicalIF":3.6000,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Pathology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.ajpath.2025.09.016","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PATHOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Colonoscopy screening effectively identifies and removes polyps before they progress to colorectal cancer (CRC), but current follow-up guidelines rely primarily on histopathological features, overlooking other important CRC risk factors. Variability in polyp characterization among pathologists also hinders consistent surveillance decisions. Advances in digital pathology and deep learning enable the integration of pathology slides and medical records for more accurate progression risk prediction. Using data from the New Hampshire Colonoscopy Registry, including longitudinal follow-up, a transformer-based model for histopathology image analysis was adapted to predict 5-year progression risk. Multi-modal fusion strategies were further explored to combine clinical records with deep learning-derived image features. Training the model to predict intermediate clinical variables improved 5-year progression risk prediction (AUC = 0.630) compared to direct prediction (AUC = 0.615, p = 0.013). Integrating WSI-based model predictions with non-imaging features further improved performance (AUC = 0.672), significantly outperforming the non-imaging-only approach (AUC = 0.666, p = 0.002). These results highlight the value of integrating diverse data modalities with computational methods to enhance progression risk stratification.
期刊介绍:
The American Journal of Pathology, official journal of the American Society for Investigative Pathology, published by Elsevier, Inc., seeks high-quality original research reports, reviews, and commentaries related to the molecular and cellular basis of disease. The editors will consider basic, translational, and clinical investigations that directly address mechanisms of pathogenesis or provide a foundation for future mechanistic inquiries. Examples of such foundational investigations include data mining, identification of biomarkers, molecular pathology, and discovery research. Foundational studies that incorporate deep learning and artificial intelligence are also welcome. High priority is given to studies of human disease and relevant experimental models using molecular, cellular, and organismal approaches.